CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati - Pharmaceutical Technology

The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the takeover was first disclosed.

Raccontata dailsole24ore.comilrestodelcarlino.itlecho.bemilanofinanza.itlastampa.itrepubblica.ittg24.sky.itstartmag.itlettera43.itcorriere.itvalor.globo.compharmaceutical-technology.com